Genetically engineered mice and rats are widely used as models for defining the molecular mechanisms underlying cancer etiology and for evaluating new strategies for cancer treatment and prevention. The Genome Editing and Animal Models Shared Resource (GEAM), formerly the Transgenic and Mutant Animal Facility, has served as a shared resource for the University of Wisconsin Carbone Cancer Center (UWCCC) for over two decades and is one of the elite facilities within the United States in offering a comprehensive array of services related to generation and preservation of genome-edited animal models. The primary mission of the GEAM is to make state-of-the-art genome editing technologies accessible to UWCCC members.
Specific Aim 1 is to provide the expertise and infrastructure required to generate novel and relevant genome-edited or transgenic animal models and genome-edited cell models for use in cancer research. GEAM staff are capable of serving UWCCC members in all aspects of experiment planning and execution, including design of efficient and specific approaches to achieve the desired loss, gain, or alteration of gene function using CRISPR/Cas9 or other genome editing and transgene-based approaches; design, production and use of the required genome editing reagents or transgene vectors; identification of animals that carry the desired genome edit or transgene; and minimization of off target edits. Our skills in reproductive biology, embryo manipulation, and animal husbandry enable us to edit the genomes of inbred mouse and rat strains that exhibit low reproductive capacity.
Specific Aim 2 is to provide state-of-the-art services that allow valuable animal models to be banked and recovered as needed to preserve these animal models or reduce the costs associated with maintaining live breeding stock for novel models that are not actively being studied. GEAM staff are highly experienced and capable of cryopreserving mouse and rat embryos or sperm and recovering mouse and rat models through embryo transfer or in vitro fertilization. In addition, we are capable of rederiving mouse and rat strains to eliminate pathogens that may compromise research or prevent animal models from being imported into our vivaria or shared between investigators working at different institutions. Since its inception, GEAM has generated hundreds of transgenic, knockout, and genome-edited mouse and rat models for UWCCC members. Sixty-one unique UWCCC members have been served during the current CCSG funding cycle, an increase of 30% compared to the previous grant cycle. Support from the CCSG allows our services to be provided to UWCCC members at costs far below those of commercial vendors or similar cores at other research universities. Convenient access to our first rate, cost-effective services enhances the ability of UWCCC investigators to conduct innovative research that advances the UWCCC strategic mission.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014520-44
Application #
9490017
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-30
Budget End
2019-03-31
Support Year
44
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Deming, Dustin A (2018) Tailoring the colorectal cancer disease assessment to the treatment strategy. Gut 67:996-997
Ferreira, Carolina A; Ni, Dalong; Rosenkrans, Zachary T et al. (2018) Scavenging of reactive oxygen and nitrogen species with nanomaterials. Nano Res 11:4955-4984
Ehlerding, Emily B; Ferreira, Carolina A; Aluicio-Sarduy, Eduardo et al. (2018) 86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model. Mol Pharm 15:2606-2613
Ehlerding, Emily B; Lan, Xiaoli; Cai, Weibo (2018) Predicting PD-1/PD-L1 status in bladder cancer with 18F-FDG PET? Eur J Nucl Med Mol Imaging :
Zhang, Fan; Braun, Doug R; Ananiev, Gene E et al. (2018) Biemamides A-E, Inhibitors of the TGF-? Pathway That Block the Epithelial to Mesenchymal Transition. Org Lett 20:5529-5532
Saghiri, Mohammad Ali; Asatourian, Armen; Sheibani, Nader (2018) Angiogenesis and the prevention of alveolar osteitis: a review study. J Korean Assoc Oral Maxillofac Surg 44:93-102
Pandhi, Nancy; Kraft, Sally; Berkson, Stephanie et al. (2018) Developing primary care teams prepared to improve quality: a mixed-methods evaluation and lessons learned from implementing a microsystems approach. BMC Health Serv Res 18:847
Aluicio-Sarduy, Eduardo; Ellison, Paul A; Barnhart, Todd E et al. (2018) PET radiometals for antibody labeling. J Labelled Comp Radiopharm 61:636-651
Slosarek, Erin L; Schuh, Amber L; Pustova, Iryna et al. (2018) Pathogenic TFG Mutations Underlying Hereditary Spastic Paraplegia Impair Secretory Protein Trafficking and Axon Fasciculation. Cell Rep 24:2248-2260
Tomko, Lucas A; Hill, Ryan C; Barrett, Alexander et al. (2018) Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma. Sci Rep 8:12941

Showing the most recent 10 out of 1528 publications